Large minority not supplying Hep C drugs: poll results

Over a fifth of respondents are not providing the new Hepatitis C treatments to patients, an AJP survey has found.AJP ran a poll to examine to what extent the cash flow issues around the medicines were affecting pharmacies’ decisions to supply patients with the drugs, and found that 22% were not providing them at all.While